Radiopharm Theranostics (ASX:RAD) | Webinar with Riccardo Canevari | 26/11/24

Watch our webinar with Radiopharm Theranostics, featuring Managing Director and CEO Riccardo Canevari.

The webinar commences with a presentation by Riccardo, followed by a live Q&A with the audience.

Key topics:
-Funding and key investors
-Dual listing at Nasdaq
-Commercial potential for the 3 clinical programs.

Radiopharm Theranostics (ASX “RAD”) is a clinical stage radiopharmaceutical company developing Therapeutic and Imaging products using peptides, small molecules, nanobodies and antibodies. With three molecules in clinical stage and three molecules in late preclincial, RAD has a very deep pipeline of innovative radiopharmaceuticals.

//

The information provided in our webinars are for general advice purposes only and should not be construed as a recommendation or endorsement of any financial product or security.

Sharewise is a stock trading platform seamlessly integrated with expert advice. We will be launching later this year. Keep an eye out for updates.

Website: www.sharewise.com.au
Facebook:   / sharewiseau  
LinkedIn:   / sharewiseau  
Instagram:   / sharewise  
TikTok:   / sharewiseau